Quick Answer
Elevance Health, Inc. reported Long-Term Debt of $30.80 billion for fiscal year 2025.
Elevance Health, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $30.80B | +5.4% |
| 2024 | $29.22B | +25.7% |
| 2023 | $23.25B | +4.0% |
| 2022 | $22.35B | +5.6% |
| 2021 | $21.16B | +9.4% |
| 2020 | $19.34B | +8.7% |
| 2019 | $17.79B | +3.3% |
| 2018 | $17.22B | -0.9% |
| 2017 | $17.38B | +21.1% |
| 2016 | $14.36B | -6.3% |
| 2015 | $15.32B | +9.3% |
| 2014 | $14.02B | +3.3% |
| 2013 | $13.57B | -4.2% |
| 2012 | $14.17B | +67.4% |
| 2011 | $8.47B | +3.9% |
| 2010 | $8.15B | -2.3% |
| 2009 | $8.34B | +6.4% |
| 2008 | $7.83B | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.17B | +26.3% | +10.6% |
| June 30, 2025 | $28.18B | +14.7% | +0.2% |
| March 31, 2025 | $28.11B | +27.9% | -3.8% |
| December 31, 2024 | $29.22B | +25.7% | +18.3% |
| September 30, 2024 | $24.69B | +2.7% | +0.5% |
| June 30, 2024 | $24.56B | -1.2% | +11.8% |
| March 31, 2024 | $21.98B | -12.8% | -5.5% |
| December 31, 2023 | $23.25B | +4.0% | -3.3% |
- Elevance Health, Inc. showed an increase of +5.4% in Long-Term Debt compared to the prior fiscal year.
- Over the 2008–2025 period, Elevance Health, Inc.’s long-term debt has grown by 293.1% (from $7.83 billion to $30.80 billion).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: